Opinion: STAT+: It’s the 50th anniversary of the U.S. biotech industry. What will the next 50 years look like?

AI Briefing

• – The U.S. biotech industry faces infrastructure challenges, including regulatory hurdles and workforce shortages.
• – The next 50 years will depend on a more effective policy framework, including investments in research and development, and addressing patent and liability issues.
• – The industry must also prioritize diversity and inclusion to maintain talent and innovation.